These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 23531116)
1. Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience. Montecucco F; Cea M; Bauer I; Soncini D; Caffa I; Lasigliè D; Nahimana A; Uccelli A; Bruzzone S; Nencioni A Curr Drug Targets; 2013 Jun; 14(6):637-43. PubMed ID: 23531116 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities. Chen H; Wang S; Zhang H; Nice EC; Huang C Expert Rev Anticancer Ther; 2016 Aug; 16(8):827-38. PubMed ID: 27186719 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells. Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders. Montecucco F; Cea M; Cagnetta A; Damonte P; Nahimana A; Ballestrero A; Del Rio A; Bruzzone S; Nencioni A Curr Top Med Chem; 2013; 13(23):2930-8. PubMed ID: 24171767 [TBL] [Abstract][Full Text] [Related]
5. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism. Burgos ES Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. Busso N; Karababa M; Nobile M; Rolaz A; Van Gool F; Galli M; Leo O; So A; De Smedt T PLoS One; 2008 May; 3(5):e2267. PubMed ID: 18493620 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel nicotinamide phosphoribosyl transferase (NAMPT) inhibitor via in silico screening. Takeuchi M; Niimi T; Masumoto M; Orita M; Yokota H; Yamamoto T Biol Pharm Bull; 2014; 37(1):31-6. PubMed ID: 24389478 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review. Gasparrini M; Giovannuzzi S; Nocentini A; Raffaelli N; Supuran CT Expert Opin Ther Pat; 2024 Jul; 34(7):565-582. PubMed ID: 38861278 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress. Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721 [TBL] [Abstract][Full Text] [Related]
12. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death. Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317 [TBL] [Abstract][Full Text] [Related]
13. Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy. Ozgencil F; Gunindi HB; Eren G Bioorg Chem; 2024 Aug; 149():107509. PubMed ID: 38824699 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma. Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332 [TBL] [Abstract][Full Text] [Related]
16. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives. Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254 [TBL] [Abstract][Full Text] [Related]
17. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD Pi C; Yang Y; Sun Y; Wang H; Sun H; Ma M; Lin L; Shi Y; Li Y; Li Y; He X Aging (Albany NY); 2019 Jun; 11(11):3505-3522. PubMed ID: 31175267 [No Abstract] [Full Text] [Related]
18. Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy Stores. Kropp EM; Broniowska KA; Waas M; Nycz A; Corbett JA; Gundry RL Stem Cells Transl Med; 2017 Apr; 6(4):1191-1201. PubMed ID: 28224719 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. Sampath D; Zabka TS; Misner DL; O'Brien T; Dragovich PS Pharmacol Ther; 2015 Jul; 151():16-31. PubMed ID: 25709099 [TBL] [Abstract][Full Text] [Related]
20. Nicotinamide phosphoribosyltransferase production in human spermatozoa is influenced by maturation stage. Riammer S; Garten A; Schaab M; Grunewald S; Kiess W; Kratzsch J; Paasch U Andrology; 2016 Nov; 4(6):1045-1053. PubMed ID: 27566659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]